Skip to main content
. 2012 Nov 19;5(2):453–456. doi: 10.3892/etm.2012.818

Table I.

Clinical treatment schemes of all patients.

No. Volume (cm) Fractions Total dose (Gy) Biological equivalent doses (Gy) CIK cell infusions
1–1 15x9.5x18 8 35 50 0
1–2 5.7x3x4.4 5 30 47 0
1–3 4x4x4 5 30 47 0
1–4 6x5x8 5 35 58 0
1–5 4.5x4.5x5, 3x3.5x2 5 35 58 0
1–6 4x3x3 5 35 58 0
1–7 3x3x1.6 4 25 39 0
1–8 2.5x2.5x2.5 6 47 84 0
1–9 6x6x8 5 40 72 0
1–10 3x2x3, 2x2x3 5 40 72 0
1–11 7x7x7 5 35 58 0
2-1 7x7x7 5 35 58 4
2–2 8x8x3 6 42 73 4
2–3 10x7x10 6 40 66 2
2–4 3x6x6, 4x3x6 5 35 58 2
2–5 3.5x4x3 3 36 78 2
2–6 7.8x8.2x6 5 35 58 2
2–7 8x7x8.5, 1.4x2.5x4.5 5 33 55 2
2–8 5x4x2.5 5 29 45 2
2–9 10x10x10 5 30 47 2
2–10 3.2x2.7x4, 1.4x1.4x1 5 24 35 2
2–11 8.0x2.3x4.5 5 33 55 2

CIK, cytokine-induced killer.